Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients

By Wang Ping   Mao Yong   Razo Juan   Zhou Xiaobo   Wong Stephen TC   Patel Samir   Elliott Erin   Shea Erin   Wu Alan HB   Gaber A Osama  

Pharmacogenomics, Vol. 11, Iss. 10, 2010-10 ,pp. : 1389-1402

Future Medicine

Access to resources Recommend Favorite

Low-dose oral tacrolimus effective in refractory IBD

By  

Inpharma, Vol. 1, Iss. 1395, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Sirolimus dominates tacrolimus post-renal transplant

By  

Inpharma, Vol. 1, Iss. 1524, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Comparison of Anti-Xa Activity After a Single Intravenous Bolus of Low-dose Enoxaparin in Patients With and Without End-stage Renal Disease

By Lin J-S   Wang W-J   Lin W-C   Wu X-M   Chao C-L  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 1890-1896

Field House Publishing

Access to resources Recommend Favorite

Low-Dose Bezafibrate-Associated Myositis in a Patient with Chronic Renal Failure

By Gotsman I.  

Clinical Drug Investigation, Vol. 18, Iss. 6, 1999-12 ,pp. : 481-483

Adis International

Access to resources Recommend Favorite